Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Analyst Confidence Rises for Casella Waste Following Leadership Transition

Dieter Jaworski by Dieter Jaworski
January 7, 2026
in Analysis, Industrial
0
Casella Waste Stock
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

Shares of Casella Waste Systems saw significant gains in today’s trading session, propelled by a bullish rating upgrade from Jefferies Financial Group. This positive shift in sentiment coincides with a historic change in the company’s executive leadership.

Jefferies Joins Bullish Chorus with Strong Buy Rating

Market strategist Stephanie Moore at Jefferies revised her firm’s stance on the waste management company, elevating it from “Hold” to “Strong Buy.” Accompanying this upgrade, the analyst institution established a fresh price target of $120 per share. This new target implies an approximate upside potential of 16% from the stock’s price level prior to the announcement. Following the news, the equity advanced roughly 3.2%, trading near $103.30.

With this move, Jefferies aligns itself with a predominantly optimistic view on Wall Street. Raymond James already maintains a “Strong Buy” recommendation with an identical $120 price objective. The consensus price target among covering analysts currently stands at approximately $114.33.

Financial Performance and a Historic CEO Succession

The timing of the upgrade is notable, as it follows a strategic leadership transition that took effect at the start of the year. Edmond “Ned” Coletta assumed the role of Chief Executive Officer on January 1, succeeding John W. Casella. Coletta marks only the second CEO in the firm’s five-decade history.

Should investors sell immediately? Or is it worth buying Casella Waste?

The company’s recent financial results provide a solid foundation for this optimism. For the quarter ending September 30, revenue climbed 17.9% year-over-year to reach $485.35 million. Earnings per share came in at $0.42, surpassing analyst expectations of $0.33.

Premium Valuation and Strategic Outlook

Investors are currently pricing Casella Waste at a significant premium, as evidenced by a price-to-earnings ratio near 430. This lofty multiple reflects substantial growth expectations from the market and sits well above industry averages.

Market participants are now keenly focused on the new CEO’s strategy for steering the company’s growth trajectory into 2026. The upcoming quarterly report, anticipated for late January or early February, is expected to deliver Coletta’s first strategic commentary alongside updated financial guidance.

Ad

Casella Waste Stock: Buy or Sell?! New Casella Waste Analysis from March 25 delivers the answer:

The latest Casella Waste figures speak for themselves: Urgent action needed for Casella Waste investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Casella Waste: Buy or sell? Read more here...

Tags: Casella Waste
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Next Post
BioNTech Stock

BioNTech Faces Legal Challenge Following Strategic Acquisition

ASTeMobile Stock

AST SpaceMobile Shares Plunge Following Severe Analyst Downgrade

Apollo Global Management Stock

Apollo's Strategic Pivot: Financing the AI Infrastructure Boom

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com